The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / New Genetic Loci Identified, Epigenome Explored in Juvenile Idiopathic Arthritis

New Genetic Loci Identified, Epigenome Explored in Juvenile Idiopathic Arthritis

April 19, 2017 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF
science photo/shutterstock.com

science photo/shutterstock.com

WASHINGTON, D.C.—Researchers have identified nine new genetic loci linked with juvenile idiopathic arthritis (JIA), along with evidence that at least some of them likely play a functional role, such as cytokine signaling and T cell expression.

You Might Also Like
  • Cancer Risk for Patients with Juvenile Idiopathic Arthritis Taking TNF Inhibitors
  • How Juvenile Idiopathic Arthritis Affects Patients, Families
  • Draft Guidelines & Recommendations for Juvenile Idiopathic Arthritis
Explore This Issue
April 2017
Also By This Author
  • The ACR, EULAR Partner to Refine Classification System, Develop New SLE Criteria

The findings were presented in an abstract session at the 2016 ACR/ARHP Annual Meeting, which also included a presentation on findings on the epigenome in JIA.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Genetic Loci Linked to JIA

Researchers pooled 2,751 cases and 15,886 controls from cohorts previously studied, with an eye toward a large, homogeneous population.1 Many previous cohorts have included patients with all of the seven different subtypes of JIA. This cohort included only the similar oligo and rheumatoid factor-negative polyarthritis subtypes, said presenter Laura McIntosh, a graduate student and researcher at the Cincinnati Children’s Medical Center.

In their genome-wide association study, researchers found nine associated regions: JAK1, PRR9_LOR, PTH1R, ILDR1_CD86, FLJ41649, AHI1_LINC00271, HBP1, WDFY4 and RNF215. All had P values of at least 1 x 10(-6), suggesting significance, Ms. McIntosh said. None reached the threshold for genome-wide significance of 1 x 10(-8), but two came close: PRR9_LOR at 5.12 x 10(-8) and ILDR1_CD86 at 6.73 x 10(-8).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Some of these loci are already known to have relevance in immunology. JAK1 elicits signals from cytokines, such as interleukin (IL) 2 and IL-21, to induce IL-17 and IL-6 production. And CD86, which is expressed on antigen-presenting cells, causes stimulation of T cell-expressed CD28 and inhibition of T cell-expressed CTLA-4.

Four of the regions—JAK1, PTH1R, AHI1 and WDFY4—have been found to have roles in other autoimmune diseases, including celiac disease, multiple sclerosis and lupus. But five of the loci appear to be unique to JIA, Ms. McIntosh said.

To assess the functional implications of these loci, researchers queried two expression-quantitative trait loci (eQTL) databases to see whether any of them could affect the expression of their own genes or nearby genes. They found this to be the case for five of the loci.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“This lends to an important regulatory impact on these associated genes,” Ms. McIntosh said.

They also analyzed the single nucleotide polymorphisms (SNPs) for histone modifications in seven cells and found that “there’s evidence for a link between associated loci and potential functional consequences that could affect gene expression,” Ms. McIntosh said.

‘When you look at the histone marks, you see quite different epigenomes in patients with juvenile arthritis,’ Dr. Jarvis said. … ‘These [histone] marks were so significant that you could actually crisply sort out active disease from healthy controls both for K4 mono-methylation & K27 acetylation.’

Epigenetic Markers

In another JIA study, researchers found that neutrophils in children with the disease have epigenetic markers that aren’t seen in healthy children, and that the JIA neutrophil epigenome shows a high degree of plasticity, reorganizing over the course of therapy.2

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Meeting Reports, Systemic Inflammatory Syndromes Tagged With: 2016 ACR/ARHP Annual Meeting, American College of Rheumatology, epigenetic, epigenome, genetic loci, inflammatory syndrome, JIA, Juvenile idiopathic arthritis, Research, rheumatologyIssue: April 2017

You Might Also Like:
  • Cancer Risk for Patients with Juvenile Idiopathic Arthritis Taking TNF Inhibitors
  • How Juvenile Idiopathic Arthritis Affects Patients, Families
  • Draft Guidelines & Recommendations for Juvenile Idiopathic Arthritis
  • Fulbright Scholar Researches Physical Activity in Swedish Children with Juvenile Idiopathic Arthritis

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)